A dozen prior leaders of the U.S. Food and Drug Administration issued a scathing denunciation of an FDA memo to staff that ...
Twelve former U.S. FDA commissioners said on Wednesday they were deeply concerned about proposed changes to vaccine ...
Twelve former commissioners, in a New England Journal of Medicine article, said they were “deeply concerned” by a leaked memo from the Trump administration’s chief scientific officer.
NEW YORK, Dec 3 (Reuters) - Twelve former U.S. FDA commissioners said on Wednesday they were deeply concerned about proposed ...
In an article that reads like informal guidance, U.S. FDA Commissioner Marty Makary and CBER Director Vinay Prasad discussed the criteria for using the agency’s novel plausible mechanism pathway for ...
In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory pathway that could trigger a seismic shift in how bespoke gene editing therapies ...
WASHINGTON, DC – Dr. Vinay Prasad has been reinstated to a senior position at the Food and Drug Administration, according to an August 9 statement from the Department of Health and Human Services (HHS ...
After the deaths of three patients, the maker of an investigational gene therapy stopped shipments of the drug after it refused a request from the U.S. Food and Drug Administration (FDA) to pull the ...
(Reuters) -Vinay Prasad has regained his role as the U.S. Food and Drug Administration's chief medical and scientific officer, according to an update on the health agency's website. Last month, Prasad ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results